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Abstract
The solution structure of the Bacillus subtilis protein YndB has been solved using NMR in order
to investigate proposed biological functions. The YndB structure exhibits the helix-grip fold,
which consists of a β-sheet with two small and one long α-helix, forming a hydrophobic cavity
that preferentially binds lipid-like molecules. Sequence and structure comparisons to proteins from
eukaryotes, prokaryotes, and archaea suggest that YndB is very similar to the eukaryote protein
Aha1, which binds to the middle domain of Hsp90 and induces ATPase activity. Based on these
similarities, YndB has been classified as a member of the Activator of Hsp90 ATPase homolog-
like protein (AHSA1) family with a function that appears to be related to stress response. An in
silico screen of a compound library of ~18,500 lipids was used to identify classes of lipids that
preferentially bind YndB. The in silico screen identified, in order of affinity, the chalcone/
hydroxychalcone, flavanone, and flavone/flavonol classes of lipids, which was further verified by
2D 1H-15N HSQC NMR titration experiments with trans-chalcone, flavanone, flavone, and
flavonol. All of these compounds are typically found in plants as precursors to various flavonoid
antibiotics and signaling molecules. The sum of the data suggests an involvement of YndB with
the stress response of B. subtilis to chalcone-like flavonoids released by plants due to a pathogen
infection. The observed binding of chalcone-like molecules by YndB is likely related to the
symbiotic relationship between B. subtilis and plants.
INTRODUCTION
The Bet v 1 protein from birch is a major allergen with high sequence similarity to the plant
PR-10 pathogenesis-related proteins, which are involved in the response of plants towards
microbial infection.1 Since the Bet v 1 protein structure was solved,2 numerous other
proteins from among eukaryotes, archaea, and bacteria have been identified as having the
same characteristic fold.3 The Bet v 1-like superfamily of proteins now contains
approximately 10,135 sequences and consists of 13 unique families. The four largest
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families in the Bet v 1-like superfamily are the polyketide cyclases (3,475 sequences), the
ring hydroxylases α-chain (2,022 sequences), the activator of Hsp90 ATPase homolog 1-like
protein (AHSA1) family (1,762 sequences), and the StAR-related lipid transfer (START)
family (1,026 sequences). The sequence similarity among the different Bet v 1-like families
tends to be relatively low (0 to 38%), but all contain the same helix-grip fold that forms a
hydrophobic cavity in between the long C-terminal α-helix and the antiparallel β-sheet.3
This hydrophobic cavity has been shown to preferentially bind to lipids, sterols, polyketide
antibiotics, and other hydrophobic molecules.3
While the Bet v 1-like superfamily members share a similar fold, the biological functions
vary across the different families. The ring hydroxylases degrade polycyclic aromatic
hydrocarbons into non-aromatic cis-diols,4 the START family appears to be involved in
steroidogenesis,5,6 while the polyketides cyclase family is involved with the biosynthesis of
polyketide-based antibiotics and pigments.7 Members of the AHSA1 family are named after
the human activator of Hsp90 ATPase protein (Aha1). While the proteins of this family have
similar structures, the functions for most of the AHSA1 family members, except for its
namesake, are ambiguous and are currently classified by UniProtKB8 as either a general
stress protein or a conserved putative protein of unknown function. The eukaryotic protein
Aha1 is proposed to interact with the middle domain of heat shock protein 90, which
stimulates its ATPase activity.9,10 The domain organization of many homologous eukaryotic
proteins in the AHSA1 family also suggests a function that is similar to Aha1. Conversely,
homologous prokaryotic proteins have a much more diverse domain organization suggesting
a wide range of possible functions.3
Of the 80 total structures solved for 59 members of the Bet v 1-like superfamily, 32 have
ligands bound. The types of ligands that have been experimentally determined to bind Bet v
1-like proteins include membrane lipids, plant hormones, secondary metabolites, polycyclic
aromatic hydrocarbons, and DNA/RNA.3 There are 12 total proteins in the AHSA1 family
with known structures. The only protein in the AHSA1 family with a solved structure of its
protein-ligand complex is the self-sacrificing resistance protein CalC from Micromonospora
echinosporato,11 where CalC is shown bound to calicheamicin γ1,12 a potent antitumor
antibiotic. Both Pfam13 and SCOP14 databases classify CalC as belonging to the AHSA1
family due to its 43 to 55% sequence similarity to other uncharacterized bacterial members
of AHSA1. CalC, however, contains a break in the C-terminal helix that is uncharacteristic
of most Bet v 1-like proteins and would likely indicate a new CalC-like family within the
Bet v 1-like superfamily. This leaves only the human Aha1 with a proposed function within
the AHSA1 family.
The Bacillus subtilis YndB protein is a protein of unknown biological function targeted for
structural analysis by the Northeast Structural Genomics Consortium (NESG;
http://www.nesg.org; NESG target: SR211). We previously reported the near complete
NMR assignments for B. subtilis YndB,15 where the protein was originally identified as
being a member of the START15,16 domain due to the similar helix-grip fold found in the
structure of two homologous proteins and based on CATH comparisons.17 The NMR
structures reported for Bacillus cereus protein BC4709 (PDB ID: 1xn6) and Bacillus
halodurans protein BH1534 (PDB ID: 1xn5) led to their START domain classification.16
These two proteins are 64 and 57% homologous to YndB, respectively, inferring a similar
annotation for YndB. However, the SCOP and Pfam databases have suggested that YndB,
BC4709, and BH1534 belong to the AHSA1 family. Sequence similarity searches with
YndB only identify proteins annotated as either AHSA1 or proteins of unknown function.
The primary difference between the START domain and AHSA1 structures is that START
domain proteins typically contain two additional N-terminal β-strands and an α-helix, which
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also makes the proteins larger. The structure of BC4709 and BH1534 do not have these
additional structural components further supporting the AHSA1 classification.
Assigning a function to an uncharacterized protein like YndB can be a daunting task that
involves obtaining a high-resolution structure18 combined with detailed studies that may
include generating knockout libraries to analyze cell phenotypes, monitoring gene
expression levels, or performing pull-down assays, all of which require in-depth
bioinformatics analyses.19–23 Since the biological function of a protein is, by definition,
derived from its interactions with other biomolecules or small molecules, identifying
interacting partners is an alternative route to obtaining a functional annotation. One such
technique, FAST-NMR,24,25 utilizes a small biologically-focused compound library
combined with NMR high-throughput screening (HTS), rapid protein-ligand co-structures
using AutoDock26 and chemical shift perturbations,27 and a comparison of protein active
site structures (CPASS)28 to assist the functional annotation of proteins. However, the utility
of FAST-NMR relies on structural homologs being found within the diverse functional
chemical library. In the case of YndB, the known Bet v 1-like superfamily ligands combined
with the expected hydrophobic cavity for YndB already suggests the protein is likely to bind
lipid-like molecules. This eliminates the need for screening a diverse array of compounds
found in the FAST-NMR compound library and instead requires an extensive screen against
a focused lipid-like library. Due to the large number of biologically relevant lipid-like
compounds29 and the corresponding limited commercial availability, an HTS assay is not
practical or cost effective. Instead, an in silico screen30,31 provides an attractive alternative
method to identify specific classes of compounds that may interact with YndB and to focus
follow-up in vitro efforts.
To better understand the general biological role of AHSA1 proteins, the structure and
putative biological function of the B. subtilis YndB protein was determined using NMR
spectroscopy and an in silico ligand-binding screen. The three-dimensional solution
structure of YndB (PDB ID: 2kte) is reported herein and is consistent with other AHSA1
proteins. Since most Bet v 1-like and AHSA1 proteins contain a hydrophobic ligand-binding
pocket, an in silico screen of a ~18,500 lipid compound library29 was performed to identify
a particular class of lipids that preferentially bind YndB and to provide insight into its
biological function. The B. subtilis YndB protein was shown to experimentally bind trans-
chalcone, a member of an important class of antibiotics and an important plant metabolite
produced by chalcone synthase.32 Three other compounds similar in structure to chalcones
(flavanone, flavone, and flavonol) and part of the same metabolic pathway were also shown
to bind YndB, albeit weaker binders than trans-chalcone. These chalcone-like molecules are
often found as precursors to flavonoids that play a key role in plant-microbe signaling and
defense, where Bacillus strains have been shown to have a beneficial impact on plant health
by protecting against fungal and bacterial pathogens.33 This suggests B. subtilis YndB may
respond to a plant infection signal and induce a stress response.
MATERIALS AND METHODS
Solution Structure of B. subtilis YndB
Uniformly 13C, 15N-enriched YndB (152 amino acids with eight non-native residues
LEHHHHHH at the C-terminus for purification) was purified following standard protocols
used in the NESG consortium.34 The recombinant vector containing the gene for YndB was
transformed into BL21 (DE3) pMGK cells. The soluble fraction of the lysed cells was
collected and purified with a Ni-NTA affinity column (Qiagen) and gel filtration column
(HiLoad 26/60 Superdex 75 pg, Amersham Biosciences) chromatography, described in full
previously.15 The NMR sample was stored in 20 mM MES buffer, pH 6.5 (uncorrected)
with 5% D2O, 0.02% NaN3, 10 mM DTT, 5 mM CaCl2, and 100 mM NaCl. The sample
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was stored in a sealed Shigemi tube (Shigemi Inc, Allison Park, PA) at 4°C when not
actively collecting NMR data.
Initial structures of YndB were calculated using CYANA 2.1.35 The program assigned the
NOEs utilizing a homology model in the first iteration, which was based on BC4709 and
BH1534, the two protein structures with high sequence identity from Bacillus cereus (PDB
ID: 1xn6) and Bacillus halodurans (PDB ID: 1xn5), respectively. CYANA assigned a total
of 1,669 distance constraints. Additional data included 126 dihedral restraints from TALOS
and 53 hydrogen bonds based on the secondary structure from TALOS.36 The 20 final
structures of CYANA were manually inspected and two were removed due to an unusual
conformation of the N-terminus. The final 18 structures were then further refined in explicit
solvent using the RECOORD protocols in CNS.37,38 The final structures agree well with the
NMR data, which is apparent from the low root-mean square deviations (rmsd) from the
experimental distances and dihedral angles. To demonstrate that the final NOE assignments
do not result in unreasonable atomic clashes, the normalized MOLPROBITY39 clash score
of −2.08 is extremely low for NMR structures.40 Table 1 contains other important structural
statistics related to the quality of the structure. According to MOLPROBITY 85% of the
torsion angles of YndB are in the most favorable region of the Ramachandran Plot with
11.3% in the allowed regions. According to PSVS40 average rmsd for the ordered residues
of 18 structures refined with explicit solvent was 0.8 Å for backbone atoms and 1.3 Å for all
heavy atoms. The ensemble was deposited in the PDB (PDB ID: 2kte) (Figure 1A). Putative
binding sites of YndB and homologous proteins BC4709 and BH1534 were investigated and
compared using CASTp,41 which attempts to identify protein ligand binding sites and active
sites by defining the molecular surface and determining surface accessible pockets. The
three-dimensional structures of the proteins are represented here using the UCSF Chimera
package from the Resource for Biocomputing, Visualization, and Informatics at the
University of California, San Francisco (http://www.cgl.ucsf.edu/chimera).42
Sequence and Structure Similarity to YndB
In order to identify homologous proteins and elucidate a possible function, multiple
similarity comparisons were performed. The pair-wise sequence alignment of YndB to
protein sequences in a non-redundant database was performed using BLASTP43–45 and the
default BLOSUM62 scoring matrix. DaliLite v.346 was used to perform the structural
similarity comparisons of YndB (model #10) with proteins from the RCSB Protein Data
Bank. ClustalW47 was used to align the sequences of YndB and the two homologous
proteins, BC4709 and BH1534, for a detailed analysis of conserved amino acid residues that
make up functionally relevant components of each protein. The ClustalW sequence
alignments used the default settings.
Virtual Screening of a Lipid Compound Library
An in silico screen of YndB against a lipid library was performed to identify classes of lipid
molecules that are favored to bind the protein. The lipid library used in this study was
obtained from the Nature Lipidomics Gateway (www.lipidmaps.org), which contains two-
dimensional structures of 21,824 lipid molecules (as of January 2010) found in mammalian
species.29,48,49 Clearly, the lipid library is not exhaustive and many lipid molecules found in
non-mammalian organisms are not represented, but the goal of the virtual screening effort is
to identify a structural homolog to the natural ligand or to identify a particular class of lipid
that preferentially binds YndB. Eight major categories of lipids are represented in the Nature
Lipidomics Gateway library: fatty acyls (3,476 structures), glycerolipids (3,012 structures),
glycerophospholipids (1,958 structures), sphingolipids (3,376 structures), sterol lipids (2,125
structures), prenol lipids (1,156 structures), saccharolipids (13 structures), and polyketides
(6,708 structures). The eight major categories are further divided into a total of 538 distinct
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subclasses of lipid compounds. The two-dimensional structure files provided by the Nature
Lipidomics Gateway were converted into three-dimensional conformers using the program
OMEGA 2.3.250 (OpenEye Scientific Software, Santa Fe, NM). OMEGA generates a
database of multiple three-dimensional conformers for each ligand in the compound library
using fragment assembly, ring conformation enumeration, and torsion driving. In this study,
OMEGA was used to generate a maximum of 600 unique (>0.5 Å rmsd) conformers for
each lipid molecule for a total searchable database consisting of ~10,000,000 conformers.
OMEGA failed to generate conformers for 3306 of the lipid structure files. Most of these
failures occurred during the processing of the sphingolipid category of lipids (3196 out of
3376 failed) due largely to the large size and number of branches/rotatable bonds of the
molecules in this category.
The docking program FRED 2.2.551 (OpenEye Scientific Software, Santa Fe, NM) was used
for the virtual screen of YndB against the lipid library. FRED is a rigid docking program
which uses the multiple conformers of each ligand created in OMEGA and generates 100
docked poses within the defined binding site by rotating and translating the rigid molecule in
order to optimize shape complementarity. The poses of each ligand conformer are then
ranked using the built-in consensus scoring method, where only the top scoring pose is kept.
Since the conformers are rigid during this docking process, FRED has been shown to be
very fast as compared to other docking programs that allow for ligand flexibility.52 This
speed is necessary in order to screen the large lipid-like library in a reasonable amount of
time. While some accuracy may be lost due to rigid docking and a lack of a biologically
relevant conformation for the ligand, FRED was primarily used to rapidly filter out
compounds that could not fit into the YndB ligand-binding pocket. Prior to initiation of the
docking, model 10 from the YndB PDB file (PDB ID: 2kte) was prepared using FRED
Receptor 2.2.5 (OpenEye Scientific Software, Santa Fe, NM), where a high quality shape
potential grid of 3403 Å3 was generated that encompassed the proposed binding cavity.
Model 10 was selected as the target receptor for the virtual screen as it had the lowest
violation energies during the structure calculations. The lipid library compounds were
ranked using the default Chemgauss3 scoring function that includes descriptors of shape and
molecular chemical properties. Chemgauss3 incorporates steric and hydrogen bond
interactions, and protein and ligand desolvation parameters that are smooth using a Gaussian
function. The relative enrichment for each lipid class within the top 1000, the top 500, the
top 200, the top 100, and the top 50 ranked compounds were calculated according to the
following equation:
(1)
where %RE is percent relative enrichment, %AbLib is the percent abundance of a lipid class
in the Nature Lipidomics Gateway library, and %AbFRED is the percent abundance of a lipid
class observed in either the top 1000, 500, 200, 100, or 50 ranked compounds by FRED.
NMR Titration Experiment
Based on the results of the virtual screen, three classes of lipid molecules were identified as
possible binders: flavones/flavonols, flavanones, and chalcones/hydroxychalcones.
Experimental validation of these possible binders was performed using chemical shift
perturbations (CSPs) in 2D 1H-15N HSQC NMR spectra collected on a Bruker 500 MHz
Avance spectrometer equipped with a triple-resonance, Z-axis gradient cryoprobe. The
2D 1H-15N HSQC NMR experiment was collected at 298K with 32 scans, 1024 data points
and a sweep width of 15 ppm centered on the water peak at 4.693 ppm in the direct 1H-
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dimension and 128 data points with a sweep width of 36 ppm in the indirect 15N-dimension.
The ligands selected to represent each of the three potential binding lipid classes were trans-
chalcone, flavanone, flavone, and flavonol (Sigma-Aldrich, St. Louis, MO). Flavone and
flavonol belong to the same class of lipids, but there was interest in how the binding would
be affected with the addition of a polar functional group. The fatty acyl oleic acid (Sigma-
Aldrich, St. Louis, MO) was also selected as a negative control. These compounds were
selected based on availability, a simple scaffold that clearly represented the lipid class, and
cost. Each compound was dissolved in “100%” deuterated DMSO-d6 (Sigma-Aldrich, St.
Louis, MO) prior to titration. The titration analysis was performed with an 80 μM 15N-
labeled YndB sample (20 mM MES buffer, pH 6.5 with 10% D2O, 0.02% NaN3, 10 mM
DTT, 5 mM CaCl2, 100 mM NaCl, and 50 μM DSS) and increasing concentrations (ranging
from 0 to 600 μM) of each ligand. The NMR data were processed with NMRpipe53 and the
spectra viewed using NMRViewJ.54 Kaleidagraph 3.5 (Synergy Software) was used to fit
the NMR data to eqn. (2),55,56
(2)
where CSPobs is the 2D 1H-15N HSQC chemical shift perturbations, [P] is the protein
concentrations, [L] is the ligand concentration and KD is the dissociation constant.
B. subtilis YndB-ligand Co-structures
Co-structures of YndB bound to each compound used in the NMR titration experiment
(trans-chalcone, flavanone, flavone, and flavonol) were generated to analyze the ligand-
binding pocket. While a definitive identification of the binding pose of these ligands to
YndB would require extensive NMR experiments and data analysis similar to the original
effort to solve the apo-YndB structure, molecular docking can provide a rapid and reliable
NMR-based model to examine the details of the binding interactions.
AutoDock 4.0126,57 with the AutoDockTools 1.5.2 (http://mgltools.scripps.edu) graphical
interface was used to simulate 100 different binding poses for each YndB-ligand complex.
AutoDock was used instead of FRED due to the accuracy gained from flexible ligand
docking and because it is one of the most highly cited docking programs available.58 The
grid map was generated with 0.375 Å spacing with xyz grid point dimensions of 50 × 58 ×
48, which is of sufficient size to encompass the proposed binding pocket previously
identified in CASTp. The docking calculations were performed using the Lamarckian
genetic algorithm default settings with a population size of 300 and 5,000,000 energy
evaluations.
RESULTS
Solution Structure of B. subtilis YndB
The observed secondary structure and fold for B. subtilis YndB are characteristic of the
helix-grip fold found in the Bet v 1-like superfamily. The helix-grip fold consists of a β
sheet with two small and one long α-helix. The β sheet is comprised of 5 strands instead of
the normal 6. The missing short strand, which is normally β2, forms sheet like interactions
in only 2 of the 18 structures in the ensemble and appears to protect the edge of β3;
unprotected edges can be adventitious interaction sites for aggregation.59 However, the
strands are annotated 1, 3, 4, 5, and 6 to facilitate comparisons with other family members:
residues 12–18 (β1), 63–69 (β3), 73–78 (β4), 83–91 (β5), and 96–104 (β6). The three α-
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helices are comprised of residues 22–28 (α1), 33–36 (α2), and 120–143 (α3) (Figure 1B).
There is significant variability in the loop regions of the protein corresponding to residues
37–63 and 105–120. These loops appear to be important for the structure of the hydrophobic
ligand-binding cavity (Figure 1B).
Like other proteins with a helix-grip fold, YndB has an exposed hydrophobic core, likely
used in the binding of lipid-like molecules. Analysis with CASTp shows that the volume of
this putative binding cavity is 790 Å3. The core of YndB consists primarily of aromatic side
chains. One element of the YndB binding pocket is the long α3-helix. This helix is anchored
to the β sheet by residues W130, V134, and L138, which show NOE interactions to the sheet
residues S15, T17, and L18. Helix α3 has previously been identified as being crucial to the
function of the structurally related START domains.60,61 In both of these earlier studies, the
removal of part of the α3-helix eliminated ligand binding. Based on the NMR solution
structure for YndB, removing the C-terminal residues would result in α3 no longer being
associated with the β-sheet and therefore, the protein would probably not be folded properly.
Hence, we surmise that the previous results were likely due to protein instability and not the
activity of specific residues to ligand binding.
The Bet v 1-like superfamily classification for YndB and the reliability of the NMR
structure is further supported by the structural similarities to two homologous proteins,
BC4709 and BH1534 (Figure 2A, B). The YndB protein exhibits a backbone rmsd of 1.1 Å
and 1.2 Å to BC4709 and BH1534, respectively, when only secondary structural elements
are included in the alignment. The main difference among the structures lies in the loop
regions, where there appears to be a significant difference in the loop conformation of
residues 37–63 and 105–120 for YndB. This difference affects the size of the hydrophobic
cavity for YndB, where BC4709 and BH1534 have much smaller volumes (199 Å3 and 106
Å3, respectively) relative to YndB.
As expected from the high sequence identity, the sequence compositions of the ligand
binding sites are also similar (Figure 2C). Nine of the fourteen residues that line the binding
cavity are identical and predominately hydrophobic (V29, G34, F76, W78, W83, V85, F87,
W130, and L138) and two others show high similarity. While none of these residues exist
within the loop regions, the large loop from residues 37–63 is very well conserved with 16
residues being identical among the three proteins, once again indicating the importance of
these loops for ligand binding. The loop regions corresponding to residues 37–63 and 105–
120 are predicted to be conformationally flexible based on the lack of NMR assignments.62
Of the 43 amino-acids that comprise the two loop regions, a total of 21 residues are
unassigned. Correspondingly, these loop regions have a limited number of structural
constraints resulting in the observed conformational variability in the ensemble of calculated
structures (Figure 1A). While the lack of NMR assignments and NOEs suggests
conformational flexibility, these observations are not sufficient to define the loops as
dynamic and requires further experimental evidence for verification.63 Nevertheless, it is
anticipated that a bound substrate would restrict the loop conformation near the YndB ligand
binding site.
Sequence and Structure Similarity to YndB
The BLASTP search of YndB against a non-redundant protein sequence database identified
58 proteins with an E-value of 1.0 × 10−21 or lower that included BC4709 and BH1534. All
of these proteins belong to the gram-positive organisms of the order Bacillales and have
sequence identities > 39% and sequence similarities > 58%. There is a clear division in
sequence similarity between the 58 Bacillales proteins and other gram-positive bacteria
proteins homologous to YndB. The sequence similarity score drops significantly from E-
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values of 10−21 for Bacillales proteins to E-values of ≥10−9 for other gram-positive proteins.
This sequence distinction may indicate a function specific to the Bacillales organisms.
The structural similarity search using DaliLite identified 590 proteins with a Z-score over
2.0. Once again, the two proteins with the greatest structural similarity are BC4709 and
BH1534 with Z-scores of 14.0 and 14.2, respectively. The top 100 proteins with the highest
structural similarities have Z-scores ranging from 9.0 to 14.2 with sequence identities <
25%, except for BC4709 and BH1534. All of the proteins identified in this range are either
uncharacterized or members of the Bet v 1-like superfamily, which includes Bet v1-like
proteins in plants.
Virtual Screening of a Lipid Compound Library
The in silico screen of YndB with the entire Nature Lipidomics Gateway lipid library took
approximately 44 hours with the computation dispersed across 16 nodes of a Linux Beowulf
cluster. Of the 18,518 structures in the library, FRED successfully docked 17,475
compounds to YndB. The relative enrichment (eqn. 2) of each lipid class from the FRED
docking is plotted in Figure 3A. Only one lipid category, the polyketides, had a positive
relative enrichment among the top 1000 docked lipid molecules. Polyketides represent
86.8% of the molecules in the top 1000, while they only make up 37.9% of the entire
compound library for a relative enrichment of 129%. The polyketide representation
increases significantly as the cutoff for the FRED scoring energy for molecules accepted in
the top rankings is decreased. If only the top 50 docked compounds are considered, 98.0%
of these compounds are polyketides, with only one hit being a member of the fatty acyl
category. All of the polyketides identified belong to the flavonoid class of lipids. Within the
flavonoids, three subclasses emerge as favorable hits from the virtual screen: chalcones/
hydroxychalcones, flavanones, and flavones/flavonols.
The chalcone/hydroxychalcone subclass turns out to be the most significant hit since 44.9%
of the flavonoids in the top 50 hits were chalcones while they only make up 9.4% of the
library of flavonoids. The remaining flavonoids in the top 50 hits belong to the flavanone
(28.6%) and flavone/flavonol (14.3%) subclasses. The molecules from these three
subclasses all have very similar chemical structures, which consist of at least two benzene
rings while containing only a few rotatable bonds (Figure 3B).
NMR Titration Experiment
While virtual screening appears to be a useful tool for identifying particular classes of lipids
that have structural and chemical properties amenable to binding to YndB, these results
require validation by experimental methods. NMR is routinely used to evaluate protein-
ligand interactions, to measure dissociation constants (KD) and to identify ligand-binding
sites through the observation of chemical shift perturbations (CSPs).27,64–66 CSPs were
calculated by comparing the average 1H and 15N resonance changes between ligand-free and
ligand-bound YndB 2D 1H-15N HSQC NMR spectra. The advantage of this approach is the
speed and minimal amount of protein and ligand required. Unfortunately, access to the
specific lipid compounds predicted to bind YndB is very limited due to low commercial
availability and/or high cost. Based upon the in silico screening of YndB with a lipid library,
chalcones/hydroxychalcones, flavanones, and flavones/flavonols were identified to be the
most likely to bind YndB. Therefore, representative molecules were sought for each class
containing the basic structural scaffold that would likely have characteristic binding
properties. A member of the fatty acyl category of lipids was also sought for use as a
negative control.
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For the chalcone/hydroxychalcone subclass of lipids, trans-chalcone was selected to
represents the basic structural scaffold for this class. The titration of YndB with trans-
chalcone resulted in significant chemical shift perturbations (Figure 4A). Nine YndB
residues with the most significant CSPs (greater than 2 standard deviation from the mean)
were identified: Thr80, Trp105, Val111, Ile112, Val122, Met126, Trp130, Thr131, and
Ile133. These residues line the opening of the proposed binding pocket (Figure 5A)
identified by CASTp. Six more residues with significant perturbations (greater than 1
standard deviation from the mean) were also identified: Glu110, Val121, Arg123, Asp127,
Gly128, and Asn135. These amino-acids reside in the long α3-helix and contribute to a
portion of the ligand binding pocket. Their perturbation may indicate a structural change in
α3-helix upon binding. The remaining loop residues that define the binding pocket are
unassigned in apo-YndB.
The normalized CSPs for each of the nine amino acid residues were plotted as a function of
protein-ligand concentration ratios and fit to a binding isotherm (eqn. 2) to determine a
dissociation constant. trans-Chalcone binds tightly to YndB with a KD 1 μM and a
stoichiometry of 1:1. The binding stoichiometry is based on the observation that a two-site
model does not fit the data as evident by the fact the chemical shift perturbations reaches a
maximum at ~1:1 protein-trans-chalcone concentration ratio (Figure 4B). Calculating an
exact KD for trans-chalcone was not possible given the YndB concentration (80 μM) used
for the 2D 1H-15N HSQC titration experiments, significantly lowering the YndB
concentration was not feasible. Superimposed on the trans-chalcone NMR titration data
(Figure 4B) is a theoretical curve for a KD of 1 μM, implying an upper-limit for the trans-
chalcone dissociation constant.
Representing the flavanone and flavone/flavonol subclasses, flavanone, flavone, and
flavonol all showed chemical shift perturbations of the same residues found to be perturbed
in the trans-chalcone titration, indicating that all the molecules bind in a similar manner.
However, flavanone, flavone, and flavonol bound YndB significantly weaker than trans-
chalcone with dissociation constants of 32 ± 3 μM, 62 ± 9 μM, and 86 ± 16 μM, respectively
(Figure 4B). The range of the dissociation constants mirror the representation of each
subclass in the virtual screen, where chalcones were the most abundantly ranked
compounds, followed by flavanones and then the flavones/flavonols. Titration of oleic acid
to YndB, which was used to represent the fatty acyl category of the lipids, showed no
significant chemical shift perturbations and therefore no evidence of binding (data not
shown).
B. subtilis YndB-ligand Co-structures
Using AutoDock, the three-dimensional structures of trans-chalcone, flavanone, flavone,
and flavonol were each docked into the YndB binding pocket identified by CASTp and
supported by NMR CSPs. The docking of each compound did not result in much variation
between the poses for each of the ligands. Out of 100 docked poses for each ligand, at least
80 were within a 2.0 Å rmsd of each other. A comparison of the most energetically
favorable poses for each ligand shows that the compounds essentially bind with the same
orientation (Figure 5A). The docked structures are also consistent with the 1:1 binding
stoichiometry predicted by the NMR titration experiments and CSPs. Binding two or more
compounds in the YndB binding pocket is sterically prohibitive and the NMR CSPs do not
identify a secondary ligand binding site.
The AutoDock predicted free energy of binding was essentially identical for each
compound, averaging −7.2 kcal/mol and correlates with a dissociation constant of ~5 μM.
With the exception of trans-chalcone, this is a stronger binding affinity than observed for the
three compounds in the NMR titration experiments. But, predicting the actual free energy of
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binding using AutoDock has an estimated error of 2.2 kcal/mol.67 In the YndB-trans-
chalcone modeled structure, there are 14 residues that reside within 5 Å of the docked trans-
chalcone, where five of these residues are aromatic (Figure 5B). These aromatic residues
presumably have a strong influence on ligand binding and selectivity, consistent with the
hydrophobic and aromatic nature of trans-chalcone and the other flavonoids. Conversely,
the binding of trans-chalcone to YndB does not appear to involve any hydrogen bonding
interactions.
Most of the difficulty in generating an accurate protein-ligand co-structure for YndB stems
from the suspected flexibility of the two loop regions that define the hydrophobic cavity.
Any variation in the orientation of the loop sidechains directly results in changes in the
binding site conformation that may be required to accommodate a ligand. This effect can be
seen in some of the YndB structures found in the NMR ensemble. The YndB-chalcone
model and the relative trans-chalcone orientation does correlate well with the binding site
for the human phosphatidylcholine transfer protein (PC-TP) complexed with
dilinoleoylphosphatidylcholine (PDB ID: 1ln1),68 a protein structure in the related START
domain family (Figure 6). While the sequence identity between YndB and PC-TP is low
(5%), both proteins have structural similarities (3.6 Å rmsd) with binding pockets located in
the same region of the protein. However, the binding pocket of YndB is significantly smaller
than the pocket found in PC-TP due to the tighter packing of the β-sheet with the loop
regions and the long α3-helix. Nevertheless, the overlay of the YndB-chalcone model with
the PC-TP complex indicates that chalcone and the other flavonoids bind within the large
dilinoleoylphosphatidylcholine-binding pocket.
DISCUSSION
The NMR structure for B. subtilis protein YndB indicates that the protein adopts a helix-grip
fold and is clearly a member of the Bet v 1-like superfamily. The YndB structure contains an
apparent hydrophobic cavity between the long C-terminal α-helix and the antiparallel β-
sheet. Like other members of the Bet v 1-like superfamily the cavity suggests YndB binds to
lipids, sterols, polyketide antibiotics, or other hydrophobic molecules as part of its biological
function. The YndB protein was originally assigned as a START domain protein based on
the high sequence similarity to B. cereus BC4709 and B. halodurans BH1534, which were
assigned to START domains based on common structural features.15,16 Instead, SCOP and
Pfam databases have suggested that YndB belongs to the closely related AHSA1 subfamily.
Also, YndB, BC4709, and BH1534 do not have the additional N-terminal β-strands and the
additional α-helix that are characteristic of a START domain structure.3 Similarly, a
BLASTP sequence alignment search indicates YndB is more appropriately assigned as a
member of AHSA1. The BLASTP search identified 58 proteins from organisms belonging
to the gram-positive Bacillales order that are homologous to YndB with sequence identities
> 39%. The functions for prokaryotic AHSA1 family members are typically classified as
either a general stress protein or a conserved putative protein of unknown function.
Similarly, the Dali search identified a large number of structural homologs to Bet v1-like
proteins, AHSA1 family members and an abundance of hypothetical proteins or proteins of
unknown function.
To further explore the potential functional annotation of YndB, an in silico screen against a
~18,500 lipid-like chemical library was conducted. The best binders identified from the in
silico screen were from the three general lipid classes of flavones/flavonols, flavanones, and
chalcones/hydroxychalcones. Representative compounds from all three classes were
screened by NMR, where trans-chalcone, flavanone, flavone, and flavonol were all shown
to bind in the YndB hydrophobic cavity with KD values of 1 μM, 32 μM, 62 μM, and 86
μM, respectively. The fact that all four molecules chosen from the in silico were shown to
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bind YndB is rather remarkable and indicative of the inherent value of our approach. The
typical hit rate for a high-throughput screen is generally low (0.1–0.5%),69 where in silico
screens may result in improved hit rates of up to 35–90%.70–72 A model for the YndB-
chalcone complex was shown to be consistent with the binding of
dilinoleoylphosphatidylcholine to human phosphatidylcholine transfer protein, a related
START domain protein.
The binding of chalcone and flavanone to a B. subtilis protein is an intriguing observation
since these molecules are primarily found in plants as precursors to flavonoid molecules
used for antimicrobial defense, flower pigmentation, absorption of harmful UV radiation,
and signaling between plants and beneficial microbes.73–77 A number of structural
homologs to YndB identified by Dali were Bet v1-like proteins in plants. In plants,
chalcones are often synthesized from a cinnamoyl-CoA molecule followed by malonyl-CoA
additions. The conversion of the resulting molecule into chalcone is catalyzed by the protein
chalcone synthase (CHS).32 Thus, chalcone is a key substrate for antibiotics or other
flavonoid-based compounds. After the synthesis of chalcone, the chalcone isomerase (CHI)
enzyme converts chalcone to flavanone, which is another compound identified to bind
YndB. The other two binding compounds, flavone, and flavonol, are products of the various
flavonoid synthesis pathways that initiate with the chalcone scaffold.32 Bacteria do not
possess CHS or CHI proteins and thus don’t produce chalcone or flavanone. Some bacteria,
including B. subtilis, do have proteins that appear to be homologous to the CHS proteins
found in plants. These homologous proteins, known as type III polyketide synthases, appear
to be pervasive in bacteria, indicating a possible mechanism for antimicrobial biosynthesis
from chalcones, thus supporting the similarities of YndB to polyketide cyclases.7,78
Similarly, homologs of CHI have also been identified in bacteria.79 However, no type III
polyketide synthase has been identified that is known to synthesize chalcones, and
flavonoids have not been identified among the natural products of Bacillus. It seems
unlikely that B. subtilis is producing chalcone-based antibiotics. These observations support
the possibility of an exchange of genes between plants and bacteria, where these proteins are
evolved for a unique bacterial function.80
The chalcone-binding property of YndB may be related to stress response as originally
indicated based on the relationship to the eukaryotic Aha1 protein. Additionally, Bet v1-like
proteins in plants, which were shown to be structural homologs of YndB, are also primarily
related to a stress response caused by a pathogen infection. An evaluation of the genes found
near YndB in B. subtilis supports the stress response explanation. While there are numerous
uncharacterized membrane proteins identified in this cluster, one-gene codes for the
membrane bound protein amino acid permease, which is involved in spore germination. The
gene for protein BH1534 from B. halodurans also contains sporulation factors upstream and
nucleotide metabolism downstream along with numerous putative membrane proteins.
Similarly, the BC4709 gene from B. cereus has numerous membrane proteins in its cluster
but also includes an ArsR transcriptional regulator and multidrug resistance proteins. The
genes for all three of these proteins exist within regions containing stress response factors.
Many other homologous proteins contain similar gene arrangements. These consistent gene
arrangements hint at a likely stress-response mechanism, which is also supported by the
similarities of these proteins to the eukaryotic Aha1 protein. Aha1 interacts with Hsp90
whereas prokaryotes have a homologous version of Hsp90 called HtpG, which has been
shown to be induced under high heat stress conditions. It should be noted, however, there is
currently no direct correlation between HtpG and YndB or spore formation.81
B. subtilis is a plant growth promoting rhizobacterium (PGPR), which is often found on the
surface of plant roots and provides protection against pathogens through biofilm formation.
82,83 Since chalcones are a key precursor to many antibiotics used by plants, it seems
Stark et al. Page 11
Proteins. Author manuscript; available in PMC 2011 December 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
reasonable that B. subtilis has developed a mechanism of response towards chalcone-based
compounds. Therefore, we hypothesize that the YndB protein, along with the homologous
proteins BC4709 and BH1534, initiates a stress response-pathway when exposed to
chalcone or chalcone-like compounds during the plant’s response to pathogen infection.
Potentially, this stress response may either induce processes to help control plant
pathogens84 and/or lead toward spore formation to protect B. subtilis from the impending
release of antibiotics from the plant.85 Since flavonoids are routinely used as signaling
molecules between plants and microbes during pathogen infections,86 it is reasonable to
consider chalcone binding is part of the symbiotic relationship between B. subtilis and
plants.
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Figure 1.
The NMR solution structure of Bacillus subtilis protein YndB (A) a backbone trace of the 18
lowest energy conformation models and (B) a ribbon diagram where the α-helices are
colored red, the β-strands are colored yellow, and the loops are colored green.
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Figure 2.
(A) An overlay of the NMR solution structure of Bacillus subtilis protein YndB (yellow),
with Bacillus cereus protein BC4709 (blue) (PDB ID: 1xn6) and Bacillus halodurans
protein BH1534 (red) (PDB ID: 1xn5). The loops have the most divergence, where loop
conformational changes have been linked to the mechanism of ligand binding. (B) The
multiple sequence alignment from ClustalW of YndB, BC4709 and BH1534 with the 14
active site residues (< 5 Å from bound ligand) indicated in black rectangles.
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Figure 3.
Summary of the FRED in silico screening results of the Nature Lipidomics Gateway lipid
library and Bacillus subtilis protein YndB. ~18,500 lipid structures corresponding to
~10,000,000 conformers were docked into YndB. The compounds were ranked using the
FRED Chemgauss3 scoring function. (A) A plot of the relative enrichment (eqn. 1) for each
of the 8 major lipid categories within the top 1000 hits (red), the top 500 hits (green), the top
200 hits (purple), the top 100 hits (cyan), and the top 50 hits (orange). Only the polyketides
were positively enriched in the virtual screen relative to their representation in the original
lipid library. (B) The chemical structures of the four flavonoid compounds chosen to
represent the three most enriched subclasses of lipids (chalcones/hydroxychalcones,
flavanones, and flavones/flavonols) identified from the in silico screen.
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Figure 4.
(A) Overlay of the 2D 1H-15N HSQC spectra of Bacillus subtilis protein YndB titrated with
chalcone, where the chalcone concentration was increased from 0 μM (blue) to 160 μM
(cyan). The significant chemical shift perturbations of the 9 assigned amino acid residues
used to determine the dissociation constant (KD) are highlighted with a black oval and
labeled accordingly. Not all of the perturbed peaks were assigned; these residues are likely
from the loop regions. (B) NMR titration data for trans-chalcone (blue), flavanone (green),
flavone (purple), and flavonol (orange). The normalized chemical shift perturbations for the
nine most perturbed amino acid residues are plotted versus the protein-ligand concentration
ratios. The titration curves were fit to a binding isotherm (eqn. 2) using Kaleidagraph 3.5
(Synergy Software). The best-fit curves are shown as a solid line. The theoretical curve
displayed for trans-chalcone corresponds to a KD of 1 μM and represents the upper-limit for
the KD. The measured KD values are 1 μM (trans-chalcone), 32 ± 3 μM (flavanone), 62 ± 9
μM (flavone), and 86 ± 16 μM (flavonol).
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Figure 5.
(A) A representation of the Bacillus subtilis YndB protein surface using the NMR solution
structure, where amino acid residues that exhibited NMR chemical shift perturbations
(CSPs) caused by the titration of trans-chalcone, flavanone, flavone, and flavonol are
colored red (≥ 2 standard deviations from mean) and blue (≥ 1 standard deviation from the
mean). The residues with the largest CSPs can be found near the entrance to the ligand
binding cavity, while the remaining residues are associated with helix α3. Shown within the
ligand binding cavity are the docked conformations of the four ligands experimentally
determined to bind YndB: chalcone (yellow), flavanone (green), flavone (purple), and
flavonol (red). (B) The NMR solution structure of YndB docked with trans-chalcone
(green). The sidechains for the 14 amino acid residues within 5 Å of the ligand are shown
and labeled. Five aromatic sidechains surround the trans-chalcone molecule and form a
hydrophobic pocket.
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Figure 6.
A structural alignment of the human phosphatidylcholine transfer protein (PC-TP)
complexed with dilinoleoylphosphatidylcholine (PDB ID: 1ln1) with the Bacillus subtilis
YndB-trans-chalcone NMR-based model. Only trans-chalcone is shown from the YndB-
trans-chalcone structure. The structural alignment indicates the location of the docked trans-
chalcone (red) relative to PC-TP (blue) and its ligand binding pocket represented by a
transparent surface (cyan). The binding pockets of the two proteins are in the same region,
indicating a reasonable docking of trans-chalcone to YndB.
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Table 1
Structural Statistics and Atomic rms Differences
Structural Statistics for the 18 lowest energy conformations
NOE distance restraintsa
 All 1669
 interresidue sequential (|i-j| = 1) 466
 interresidue short range (1 < |i-j| < 5) 369
 interresidue long-range (|i-j| > 5) 509
 intraresidue 325
H-bonds 53
Dihedral restraints 126
Ensemble RMSDb (Å)
 Secondary structure backbone 0.8
 Secondary structure heavy 1.3
PSVS Z-scoresb
 Verify3D −2.89
 ProsaII (−ve) −1.12
 Procheck (phi-psi) −2.83
 Procheck (all) −3.90
 MolProbity Clash Score −1.73
RPF Scoresb
 Recall 0.647
 Precision 0.668
 F-measure 0.657
 DP-score 0.552
Energy(kcal/mol)c
 total −5504.8 ± 137.9
 bond 79.8 ± 4.7
 angle 272.2 ± 19.7
 dihedral 714.0 ± 5.4
 impropers 108.3 ± 8.4
 van der Waals −604.0 ± 21.4
Violationsc
 NOE > 0.5 Å 0
 Dihedral > 5° 2.6
RMSD (experimental)c
 NOE (Å) 0.0220 ± 0.001
 H-bonds (Å) 0.023 ± 0.001
 Dihedral angles (°) 1.18 ± 0.14
RMSD (covalent geometry)c
 Bonds (Å) 0.012± 0.0004
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Structural Statistics for the 18 lowest energy conformations
 Angles (°) 1.3 ± 0.04
 Impropers (°) 1.6 ± 0.08
Ramachandran spaced
 Most Favored 85.0%
 Allowed 11.3%
 Disallowed 3.7%
a
Calculated with CYANA.
b
Calculated with PSVS.
c
Calculated with CNS.
d
Calculated with MOLPROBITY
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